Research Paper Volume 15, Issue 3 pp 689—704
The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer
Figure 5. Cox regression analysis and survival analysis. (A) Univariate Cox regression analysis. (B) Multivariate Cox regression analysis. (C) The Kaplan−Meier (KM) survival analysis of BLM. (D) The KM survival analysis of IQ Motif Containing GTPase Activating Protein 3 (IQGAP3). (E) The KM survival analysis of Thymidylate Synthetase (TYMS). (F) KM survival analysis of Diaphanous Related Formin 3 (DIAPH3).